FDA Approves Groundbreaking PROTAC Drug Veppanu for Advanced Breast Cancer
Published: May 2, 2026 WASHINGTON — In a milestone for precision oncology, the U.S. Food and Drug Administration (FDA) yesterday approved Veppanu...
Canada Leads G7 with Approval of Second Generic Ozempic, Signaling Major Price Drop for Patients
OTTAWA — In a landmark move for North American drug pricing, Health Canada has approved a second generic version of semaglutide, the active...
Federal Appeals Court Issues Injunction on Mail-Order Abortion Medication: What Patients and Providers Need to Know
NEW ORLEANS — In a unanimous decision that significantly reshapes reproductive healthcare access in the United States, a three-judge panel from the...
Structural Failures in Healthcare: Lessons from the Jhansi Medical College Elevator Crash
JHANSI, India — Late on the evening of April 29, 2026, a routine movement of visitors at the Maharani Laxmibai Medical College turned into a scene...
The Hydration Purge: Why India’s ORS Market is Shrinking—and Why That’s Good for You
NEW DELHI – India’s oral rehydration solution (ORS) market, long a staple of the country’s medicine cabinets and summer survival kits, is undergoing...
